background

Drug solution for bone fracture nonunions - OSTEOforUNION

OSTEOforUNION introduces a disruptive solution - the first biological treatment that turns the patient’s own blood into bone, providing a new standard of care for FNU.

img
Our solution

OSTEOGROW-C

A Personalized Biological Implant for Bone Regeneration OSTEOGROW-C is an innovative drug-product implant designed to stimulate bone formation in difficult-to-heal fractures. It is composed of three core components:

  • rhBMP6 – a potent osteogenic growth factor
  • ABC (Autologous Blood Coagulum) – the patient’s own blood acting as a natural carrier
  • TCP ceramics – a compression-resistant matrix providing biomechanical support
Next-Gen Implant

What makes OSTEOGROW-C unique?

img

First-ever autologous osteogenic implant

img

No animal or donor-derived materials

img

Physiological carrier

img

Equally or more effective than autologous bone graft

img

Unlimited supply (unlike harvested bone)

feature-image
Minimally Invasive

Prepared directly in the operating room

Only 10 mL of the patient’s blood is needed to prepare the implant — eliminating the need for harvesting bone from the iliac crest, avoiding major complications such as chronic pain, infection, bleeding, or nerve injury.

Operating room preparation
img
Expert-Backed

Competitive Advantage

Globally patented breakthrough technology

First-in-class therapy using patient blood as a physiological carrier

Supported by world-leading experts in BMP biology

Applicable to multiple future indications (spine, long bones, trauma)

background
Beyond Nonunions

Our Long-Term Vision

Genera Research aims to establish OSTEOGROW products as the global gold standard for bone regeneration. Building on the success of OSTEOGROW-C for nonunions, we plan to expand into a full platform of regenerative solutions for orthopaedics.

Our partners

img

Our Company, Vision & Mission

At Genera Research, our mission is to elevate patient care and improve outcomes worldwide. Using our proprietary technology, we develop novel biological bone regeneration solutions that combine cutting-edge bioengineering with the body’s natural ability to self-heal in patients with skeletal diseases. Our vision is to transform lives and revolutionize orthopaedic and dental care through personalized treatments based on the patient’s own blood and biology. We aim to make regenerative solutions broadly accessible and create a future in which bone disorders no longer limit anyone’s ability to live fully, independently, and with confidence.